International Journal of Biomedical & Life Sciences (IJBLS) is an international, peer-reviewed, open-access scholarly journal dedicated to publishing high-quality research that advances scientific knowledge across the broad spectrum of biomedical, biological, and life sciences. Published by the Global Research & Publishing Database (GRPD), the journal provides a global platform for researchers, scientists, clinicians, academicians, healthcare professionals, and industry experts to disseminate innovative research, systematic reviews, clinical studies, case reports, and interdisciplinary investigations that contribute to improving human health, biological understanding, and life science innovation.

The journal recognizes that modern biomedical research increasingly depends on interdisciplinary collaboration among biological sciences, medicine, biotechnology, genetics, computational sciences, and healthcare disciplines. IJBLS therefore welcomes research that integrates diverse scientific approaches to address complex biological processes, disease mechanisms, medical innovations, public health challenges, and sustainable solutions for improving human and environmental health.

As a fully open-access journal, IJBLS is committed to ensuring that scientific discoveries remain freely accessible to researchers, clinicians, educators, policymakers, and the public worldwide. By removing access barriers, the journal seeks to accelerate scientific discovery, encourage international collaboration, and maximize the impact of biomedical and life sciences research.

Mission

The mission of IJBLS is to advance scientific knowledge by publishing original, innovative, and methodologically rigorous research that contributes to biomedical sciences, biological sciences, and healthcare. The journal aims to provide an international platform where researchers from diverse disciplines can exchange ideas, develop collaborations, and translate scientific discoveries into practical solutions that improve human health and quality of life.

Vision

The vision of IJBLS is to become a globally recognized journal of excellence in biomedical and life sciences, known for scientific quality, research integrity, editorial excellence, and international collaboration. The journal seeks to bridge fundamental biological research with clinical and translational applications that address present and future healthcare challenges.

Aims and Objectives

The primary objectives of IJBLS are to:

• Publish high-quality, original, and impactful biomedical and life sciences research.
• Promote interdisciplinary collaboration among researchers from biological, medical, and health sciences.
• Encourage innovative research addressing global health challenges.
• Support evidence-based scientific discoveries that improve healthcare and medical practice.
• Provide a fully open-access publishing platform with worldwide accessibility.
• Maintain the highest standards of editorial quality, publication ethics, and research integrity.
• Facilitate collaboration between academia, healthcare institutions, industry, and policymakers.
• Promote translational research that bridges laboratory discoveries with clinical practice.

Scope of the Journal

IJBLS welcomes original research articles, review articles, systematic reviews, meta-analyses, clinical studies, case reports, methodological papers, and interdisciplinary research covering a broad range of biomedical and life sciences disciplines.

The journal considers submissions in, but is not limited to, the following fields:

Types of Articles

IJBLS accepts various types of scholarly contributions, including:

Peer Review Process

Every manuscript submitted to IJBLS undergoes an initial editorial screening to assess its relevance, originality, scientific quality, ethical compliance, and adherence to the journal's submission requirements.

Manuscripts that successfully pass the editorial assessment are subjected to a rigorous double-blind peer review process in which both authors and reviewers remain anonymous throughout the evaluation. Independent reviewers assess submissions based on originality, scientific rigor, methodological quality, clinical relevance, ethical standards, clarity of presentation, validity of findings, and contribution to biomedical knowledge.

Editorial decisions are based solely on academic merit and scientific quality.

Publication Ethics

IJBLS adheres to internationally recognized principles of publication ethics and research integrity. Authors, reviewers, and editors are expected to comply with the highest ethical standards throughout the publication process.

The journal maintains strict policies regarding:

All manuscripts may be screened using plagiarism detection software before peer review.

Open Access Policy

IJBLS follows a fully open-access publishing model, ensuring that all published articles are freely accessible immediately upon publication without subscription barriers. Readers may read, download, distribute, and cite published articles in accordance with the journal's copyright and licensing policies.

International Audience

IJBLS welcomes submissions from researchers, clinicians, healthcare professionals, universities, hospitals, research institutes, biotechnology industries, pharmaceutical organizations, and public health agencies worldwide. By publishing internationally relevant biomedical research, the journal promotes global scientific collaboration and knowledge exchange that contributes to better healthcare outcomes and advances in life sciences.

Why Publish with IJBLS?

Our Commitment

The International Journal of Biomedical & Life Sciences (IJBLS) is committed to advancing high-quality scientific research that promotes innovation, interdisciplinary collaboration, ethical research practices, and evidence-based solutions to global biomedical and healthcare challenges. By providing a trusted international platform for scholarly communication, IJBLS seeks to contribute meaningfully to scientific discovery, clinical advancement, public health improvement, and the continued progress of biomedical and life sciences worldwide.